Investing.com -- Shares of GN Store Nord (CSE:GN) climbed 5% today after the company announced the launch of two new hearing aid platforms, ReSound Vivia and ReSound Savi, set to be available from February 20th in the U.S. and Germany, with additional markets to follow.
The new products are designed to address the primary challenge of speech understanding in noisy environments, a significant user pain point in the industry.
The launch appears to have resonated positively with investors, as the platforms echo a dual launch strategy similar to the anticipated mid-2024 Sphere Infinio & Infinio release. This strategy suggests a premium pricing model for ReSound Vivia compared to the ReSound Navi. GN Store Nord's technological advancements are not limited to the hearing aid division but are also expected to benefit its Enterprise and Gaming divisions.
ReSound Vivia is touted as the smallest AI hearing aid to date and the most advanced for speech-in-noise situations. Its dedicated deep neural network (DNN) chip reportedly outperforms competitors, being up to 17 times more efficient and resulting in 64% of users experiencing improved hearing in noise capabilities compared to other advanced AI-powered aids. Additionally, the rechargeable battery is designed to last a full day, even with AI features in use.
ReSound Savi offers technological enhancements over its predecessor, Nexia, including advanced connectivity features like Bluetooth Low Energy (BLE) and Auracast, although it does not include the second dedicated AI chip found in Vivia.
In response to the announcement, analysts at Jefferies commented, "Platform launches come earlier than we expected, which we view as a +ve, and should allow GN to sustain Hearing momentum. We reiterate our Buy rating."
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.